Effect of Platelet Concentrate in Treatment of Diabetic Ulcers
NCT ID: NCT00215735
Last Updated: 2012-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
INTERVENTIONAL
2004-06-30
2005-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Effectiveness of Topical Autologous Platelet Gel for the Treatment of Venous Ulcers
NCT00273234
Clinical Trial to Evaluate Blister Graft Utilizing a Novel Harvesting Device for Treatment of Venous Leg Ulcers
NCT02148302
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
NCT02071979
A Randomized, Controlled Trial of Autologous Platelet Gel Treatment in Diabetic Foot Ulcers
NCT00338702
Safety And Efficacy Of Topical Platelet Rich Plasma And Thrombin Coagulum
NCT02802995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
APC Treatment
wound debridement and treatment with APC
debridement, dressing, and APC
ebridement, dressing, and APC
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
debridement, dressing, and APC
ebridement, dressing, and APC
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Harvest Technologies
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Iafrati, MD
Role: PRINCIPAL_INVESTIGATOR
Tufts Medical Ctr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington Regional Medical Center
Fayetteville, Alaska, United States
Lucerne Hospital
Orlando, Florida, United States
Bay Pines V.A. Medical Center
St. Petersburg, Florida, United States
New England Medical Center Hospital
Boston, Massachusetts, United States
Traveling Medical Services
Southfield, Michigan, United States
Blair Medical Associates
Altoona, Pennsylvania, United States
Roger Williams Hospital
Providence, Rhode Island, United States
Tennessee Christian Hospital
Madison, Tennessee, United States
St. Luke's Medical Ctr
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2003-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.